概括
意外启动透析是很常见的. 科医生应监测估计的淋巴细胞过率 (eGFR),体重增加和患者预约出席率的趋势,以预测和预防紧急透析开始.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 腎臟醫學 腎臟醫學
- 公共卫生 公共卫生
背景情况:
- 为启动透析而入院的急诊医院与更糟糕的患者结果有关,包括更高的死亡率和并发症.
- 很大一部分患者,即使是接受科护理的患者,也会突然开始透析.
- 识别意外透析启动的预测因素对于改善患者护理和结果至关重要.
研究的目的:
- 为了确定与非计划性透析启动相关的透析前期特征,在已经知道脏病学服务的患者中.
- 为科医生提供可操作的洞察力,以积极主动地管理患者.
- 减少紧急透析开始的发生率及其相关风险.
主要方法:
- 追溯病例控制研究,根据年龄和性别,将40次非计划性透析启动 (病例) 与计划性启动 (控制) 相匹配.
- 从电子病历和信件中收集的数据,重点关注透析前的一年.
- 多变量分析以确定非计划性透析启动的独立预测因素.
主要成果:
- 不按计划开始透析的患者显示,估计的淋巴细胞过率 (eGFR) 降低速度更快,每月体重增加更大,脏病诊所预约更频繁错过.
- 确定的主要预测因素是eGFR轨迹 (OR 1.91),每月体重增加 (OR 1.97) 和不上诊 (OR 1.54).
- 传统的标志物,如最新的eGFR和蛋白尿,比基于趋势和参与度的指标更难预测.
结论:
- 科医生应优先监测eGFR和体重的趋势,以及患者的参与 (临床出诊),以确定高风险的非计划透析启动的个体.
- 将焦点从静态标记转移到动态趋势可以改善紧急透析开始的预测和预防.
- 积极的识别和干预可以减轻与计划外的透析启动相关的并发症.
相关概念视频
Dialysis
261
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Renal Drug Excretion: Tubular Secretion
117
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
117


